Online citations, reference lists, and bibliographies.
← Back to Search

Detection Of Macrophage Migration Inhibitory Factor (MIF) In Human Cholesteatomas And Functional Implications Of Correlations To Recurrence Status And To Expression Of Matrix Metalloproteinases‐3/9, Retinoic Acid Receptor‐β, And Anti‐apoptotic Galectin‐3

G. Choufani, R. Ghanooni, C. Decaestecker, K. Delbrouck, P. Simon, M. Schüring, Y. Zick, S. Hassid, H. J. Gabius, R. Kiss
Published 2001 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Objectives To investigate whether the expression of the macrophage migration inhibitory factor (MIF) 1) is detectable, 2) changes in relation to recurrence and infection status, and 3) relates to the levels of expression of growth regulators/differentiation markers, including galectin‐1, ‐3, and ‐8, retinoid acid receptors (RAR)]‐α, ‐β, and ‐γ, binding sites for sarcolectin, and invasion markers (cathepsins ‐B and ‐D, and matrix metalloproteinases [MMP]‐2, ‐3, and ‐9) in human cholesteatomas.
This paper references
10.1097/00005537-200106000-00020
The Levels of Expression of Galectin‐3, But Not of Galectin‐1 and Galectin‐8, Correlate With Apoptosis in Human Cholesteatomas
R. Sheikholeslam-zadeh (2001)
10.1046/J.1365-2273.1998.00159.X
Matrix metalloproteinase-2 and matrix metalloproteinase-9 in cholesteatoma and deep meatal skin.
A. Banerjee (1998)
Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
A. Albino (1998)
The level of galectin-3 expression, but not of galectin-1 and -8, correlates with apoptosis in human cholesteatomas. Laryngoscope 2001;111:1042–1047
R Sheikholeslam-Zedah (2001)
10.1288/00005537-199503000-00015
Plasminogen activators in tissue extract of aural cholesteatoma
M. Nakamura (1995)
10.1038/358015A0
p53, guardian of the genome
D. Lane (1992)
The level of galectin - 3 expression , but not of galectin - 1 and - 8 , correlates with apoptosis in human cholesteatomas
R Sheikholeslam-Zedah (2001)
Retinoic acid receptorgamma in human epidermis preferentially traps all-trans retinoic acid as its ligand rather than 9-cis retinoic acid
GJ Fisher (1998)
Cholesteatoma: a molecular and cellular puzzle.
A. Albino (1998)
Cancer. p53, guardian of the genome.
D. Lane (1992)
10.1089/10799900050151012
Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.
J. Nishihira (2000)
10.1084/JEM.190.10.1367
At the Crossroads of Inflammation and Tumorigenesis
C. Cordon-Cardo (1999)
10.11501/3182186
Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis
伸浩 小野寺 (2001)
Macrophage inhibitory factor (MIF): its essential role in the immune system and cell growth
J. Nishihira (2000)
10.1038/35041654
Signal transduction: A most interesting factor
R. Bucala (2000)
10.1006/EXCR.1996.3441
Incomplete differentiation of fetal keratinocytes in the skin equivalent leads to the default pathway of apoptosis.
A. Haake (1997)
10.1016/0014-5793(96)00120-2
Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization
T. Shimizu (1996)
10.1006/BBRC.1994.1418
Characterization of the macrophage migration inhibitory factor-binding site of sarcolectin and its relationship to human serum albumin.
F. Zeng (1994)
10.14670/HH-14.771
Detection of sarcolectin-specific receptors like the cytokine macrophage migration inhibitory factor in rheumatoid nodules.
A. Zschäbitz (1999)
10.1001/ARCHOTOL.124.3.261
Cell proliferation and apoptosis in human middle ear cholesteatoma.
H. Kojima (1998)
10.1006/BBRC.1997.7633
Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis.
T. Shimizu (1997)
10.1038/35041591
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
R. Kleemann (2000)
10.1097/00005537-199911000-00019
Determination of the Levels of Expression of Sarcolectin and Calcyclin and of the Percentages of Apoptotic But Not Proliferating Cells to Enable Distinction Between Recurrent and Nonrecurrent Cholesteatomas
G. Choufani (1999)
10.1111/j.1432-1033.1997.t01-1-00543.x
Animal lectins.
H. Gabius (1997)
10.3109/00016489609137872
Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas.
M. Schönermark (1996)
10.1177/000348949910800305
Expression Pattern of the Plasminogen Activator—Plasmin System in Human Cholesteatoma
M. Schönermark (1999)
10.1046/j.1365-2133.1999.03206.x
Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease
M. Steinhoff (1999)
Cathepsin activity in cholesteatoma.
M. Iwanaga (1985)
10.1288/00005537-199511000-00018
Expressions of c‐jun and p53 proteins in human middle ear cholesteatoma: Relationship to keratinocyte proliferation, differentiation, and programmed cell death
H. Shinoda (1995)
A most interesting factor
R. Bucala (2000)
10.1007/BF03402210
The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction
E. Rosengren (1996)
10.1096/fasebj.10.14.9002552
MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid‐induced regulator of the immune response
R. Bucala (1996)
Distinct conformations of p53 are observed at different stages of keratinocyte differentiation.
D. Spandau (1994)
10.1017/S0317167100021028
Mechanisms of glioma invasion: role of matrix-metalloproteinases.
J. Uhm (1997)
Choufani et al.: MIF Expression in Cholesteatomas 1661 cation of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization
T Shimizu (2001)
10.1046/J.1523-1747.1999.00486.X
Ultraviolet B radiation upregulates the production of macrophage migration inhibitory factor (MIF) in human epidermal keratinocytes.
T. Shimizu (1999)
10.1016/S0925-4439(99)00080-0
Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts.
R. Abe (2000)
10.1084/JEM.190.10.1375
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
J. D. Hudson (1999)
10.1093/JNCI/89.17.1260
Changing views of the role of matrix metalloproteinases in metastasis.
A. Chambers (1997)
10.1016/S0194-5998(97)60352-6
Altered regulation of cell surface peptidases in human cholesteatoma.
R. Desloge (1997)
10.1096/fasebj.10.9.8801161
Molecular mechanisms of retinoid actions in skin
G. Fisher (1996)
Prolactin upregulates cathepsin B and D expression in minor salivary glands of Sjögren’s syndrome patients
S Steinfeld (2000)
Cholesteatoma: a molecular and cellular puzzle.
Albino Ap (1998)
10.1016/S0378-5955(01)00230-1
The levels of retinoid RARβ receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas
P. Simon (2001)
10.1046/J.1523-1747.1998.00112.X
Retinoic Acid Receptor-γ in Human Epidermis Preferentially Traps All-Trans Retinoic Acid as its Ligand Rather Than 9-cis Retinoic Acid
G. Fisher (1998)
Collagenolytic activity in middle ear cholesteatoma.
M. Abramson (1969)
10.1126/SCIENCE.281.5381.1317
A matter of life and cell death.
G. Evan (1998)
10.1155/2000/36321
“Galectin-1 Induces Central and Peripheral Cell Death: Implications in T-Cell Physiopathology”
C. Sotomayor (2000)
10.1038/labinvest.3780181
Prolactin Up-Regulates Cathepsin B and D Expression in Minor Salivary Glands of Patients with Sjögren's Syndrome
S. Steinfeld (2000)



This paper is referenced by
10.1078/0344-0338-00466
Chromosomal aberrations, profiles of expression of growth-related markers including galectins and environmental hazards in relation to the incidence of chondroid pulmonary hamartomas.
K. Kayser (2003)
10.1080/00016480802251591
Increased expression of p63 and survivin in cholesteatomas
H. Park (2009)
10.1258/0022215054273269
Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
S. De (2005)
10.1002/ART.11165
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.
M. Leech (2003)
10.1016/j.heares.2006.01.013
Characterization of patterns of expression of protein kinase C-α, -δ, -η, -γ and -ζ and their correlations to p53, galectin-3, the retinoic acid receptor-β and the macrophage migration inhibitory factor (MIF) in human cholesteatomas
R. Ghanooni (2006)
10.1111/j.1600-0897.2010.00824.x
REVIEW ARTICLE: Governing the Invasive Trophoblast: Current Aspects on Intra‐ and Extracellular Regulation
J. Fitzgerald (2010)
10.1007/s00432-001-0304-3
Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma
U. Wollina (2001)
10.4176/060824
Congenital cholesteatoma tract presenting as a postaural swelling
S.R.S. Ganesh (2006)
10.1007/s00405-002-0501-y
Altered permeability barrier structure in cholesteatoma matrix
V. Svane-Knudsen (2002)
10.1046/j.1365-2559.2003.01588.x
Differential expression of S100 calcium‐binding proteins in epidermoid cysts, branchial cysts, craniopharyngiomas and cholesteatomas
P. Pelc (2003)
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
S. Cludts (2010)
10.5152/iao.2018.4976
Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.
E. Araz Server (2019)
Clinical Markers of Cholestetoma
S. Kumar (2010)
10.1089/10799900050151012
Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.
J. Nishihira (2000)
Molecular biology of cholesteatoma
Carmen Aurelia (2014)
10.1097/00005537-200307000-00018
Expression of Hypoxia Inducible Factor 1 α and Von Hippel Lindau Protein in Human Middle Ear Cholesteatoma
O. Adunka (2003)
10.4067/S0718-48162006000100007
Fisiopatología del colesteatoma originado a partir de un bolsillo de retracción
M. A. Cohen (2006)
Molecular biology of cholesteatoma.
A. Maniu (2014)
10.3109/00016489.2013.844360
44-plex cytokine profile of cholesteatoma
A. Britze (2014)
10.1007/978-3-7091-1065-2_10
Galectin-1: Forms and Functions
A. Gupta (2012)
10.1016/j.ijporl.2011.07.026
Tissue remodeling in the acute otitis media mouse model.
Nathan B. Sautter (2011)
10.1002/lary.24176
Differential Gene Expression in Cholesteatoma by DNA Chip Analysis
John D. Macias (2013)
10.1159/000091715
Immunohistochemical Detection of Macrophage Migration Inhibitory Factor in Fetal and Adult Bovine Epididymis: Release by the Apocrine Secretion Mode?
R. Eickhoff (2006)
10.1016/j.placenta.2015.09.015
Fetal gender specific expression of tandem-repeat galectins in placental tissue from normally progressed human pregnancies and intrauterine growth restriction (IUGR).
S. Hutter (2015)
10.1097/mlg.0b013e318031d09d
Animal Model for Cholesteatoma Induced in the Gerbil: Will the Profiles of Differentiation/Growth‐Regulatory Markers be Similar to the Clinical Situation?
G. Choufani (2007)
10.1097/01.MP.0000068235.45178.C1
Prognostic Values of Galectin-3 and the Macrophage Migration Inhibitory Factor (MIF) in Human Colorectal Cancers
H. Legendre (2003)
10.3171/JNS.2003.98.1.0145
Characterization of the levels of expression of retinoic acid receptors, galectin-3, macrophage migration inhibiting factor, and p53 in 51 adamantinomatous craniopharyngiomas.
F. Lefranc (2003)
tIlll " ' . " ' " COMPARISON OF SALBUTAMOL AND NIFEDIPINE IN THE TREATMENT OF PRETERM LABOUR
R. Korejo (2014)
10.1016/j.placenta.2013.07.005
Expression and function of galectins in the endometrium and at the human feto-maternal interface.
U. Jeschke (2013)
10.1034/j.1600-0463.2002.100601.x
Primary colorectal carcinomas and their intrapulmonary metastases: Clinical, glyco‐, immuno‐ and lectin histochemical, nuclear and syntactic structure analysis with emphasis on correlation with period of occurrence of metastases and survival
K. Kayser (2002)
Semantic Scholar Logo Some data provided by SemanticScholar